Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients

Transplantation Proceedings

Volumn 46, Issue 8, 2014, Pages 2636-2639

  Mazanowska, O ^a   Zabinska M ^a   Koscielska Kasprzak K ^a   Kaminska D ^a   Krajewska, M ^a   Banasik, M ^a   Madziarska, K ^a   Zmonarski, S C ^a   Chudoba, P ^a   Biecek, P ^b   Boratynska M ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TIMP2 PROTEIN, HUMAN;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEINURIA; ALLOTRANSPLANTATION; BLOOD; KIDNEY TRANSPLANTATION; METABOLISM; URINE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROTEINURIA; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSPLANT RECIPIENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84910145901     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.08.034     Document Type: Conference Paper

References (15)

1. H. Amer, M.E. Fidler, and M. Myslak Proteinuria after kidney transplantation, relationship to allograft histology and survival Am J Transplant 7 2007 2748 2756
2. H. Reichel, M. Zeier, and E. Ritz Proteinuria after renal transplantation: pathogenesis and management Nephrol Dial Transplant 19 2004 301 305
3. J. Neugarten, T. Srinivas, V. Tellis, S. Silbiger, and S. Greenstein The effect of donor gender on renal allograft survival J Am Soc Nephrol 7 1996 318 324
4. J.I. Roodnat, P.G. Mulder, and J. Rischen-Vos Proteinuria after renal transplantation affects not only graft survival but also patient survival Transplantation 72 2001 438 444
5. J.M. Halimi, I. Laouad, and M. Buchler Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation Am J Transplant 5 2005 2281 2288
6. O. Mazanowska, D. Kamińska, and M. Krajewska Imbalance of metalloproteinases/tissue inhibitors of metalloproteinase system in renal transplant recipients with chronic allograft injury Transplant Proc 43 2011 3000 3003
7. J.M. Ginsberg, B.S. Chang, R.A. Matarese, and G. Garella Use of single voided urine samples to estimate quantitative proteinuria N Engl J Med 309 25 1983 1543 1546
8. S. Torng, C. Rigatto, D.N. Rush, P. Nickerson, and J.R. Jeffery The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patients Transplantation 72 2001 1453 1456
9. H. Hohage, U. Kleyer, and D. Buckner Influence of proteinuria on long-term transplant survival in kidney transplant recipients Nephron 75 1997 160 165
10. G.A. Knoll Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management Am J Kidney Dis 54 2009 1131 1141
11. B.F. Palmer Proteinuria as a therapeutic target in patients with chronic kidney disease Am J Nephrol 27 2007 287 293
12. G. Fernandez-Fresnedo, R. Escallada, and E. Rodrigo The risk of cardiovascular disease associated with proteinuria in renal transplant patients Transplantation 73 2002 1345 1348
13. A. Sancho, E. Gavela, and A. Avila Risk factors and prognosis for proteinuria in renal transplant recipients Transplant Proc 39 2007 2145 2147
14. E. Rodrigo, M. López-Hoyos, and R. Escallada Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy Nephrol Dial Transplant 15 2000 2041 2045
15. W. Wong, J. DeVito, and H. Nguyen Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine Am J Transplant 10 2010 2463 2471